Skip to main content
OpenTrials

Clinical trial condition

Gram-Positive Bacterial Infections

Explore clinical trials studying Gram-Positive Bacterial Infections. Study availability and eligibility vary by location and protocol.

2,601 public trials 262 recruiting studies
Refine in advanced search Browse all conditions

Gram-Positive Bacterial Infections trial results

Completed

An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department

NCT01899365

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Disease Attributes, +7 more
Locations
  • Centre Hospitalier Universitaire de Clermont-Ferrand Clermont-Ferrand, France
  • Centre Hospitalier Paul Ardier Issoire, France
  • AP-HM - Hôpital Nord Marseille, France
  • AP-HM - La Timone Marseille, France
View all 18 locations
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

NCT02853929

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
Locations
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Calgary, Alberta, Canada
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
View all 29 locations
View Trial Details
Completed

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

NCT00352963

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations
  • GSK Investigational Site Alcorcón, Spain
  • GSK Investigational Site Almeira, Spain
  • GSK Investigational Site Badalona, Spain
  • GSK Investigational Site Barcelona, Spain
View all 22 locations
View Trial Details
Completed

Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.

NCT00609492

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Athens, Greece
  • GSK Investigational Site Athens, Greece
  • GSK Investigational Site Ioannina, Greece
  • GSK Investigational Site Thessaloniki, Greece
View Trial Details
Completed

Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.

NCT00835237

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site DeLand, Florida, United States
  • GSK Investigational Site West Palm Beach, Florida, United States
View all 24 locations
View Trial Details

Related conditions